Primer: ClouDr Group (9955 HK) - Aug 2026
ClouDr Group is a digital healthcare provider in China facing significant fundamental headwinds, evidenced by a sharp decline in revenue and...
94 Views
DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational
​DeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...
417 Views
DeepSeek Ignites China Healthcare - The Investment Opportunities and Risks Behind
DeepSeek is revolutionizing the healthcare industry, but face data security issue and US restriction on cooperation with China.Companies...
695 Views
Pre-IPO WeiMai - The Pain Points Behind the Business Model
​WeiMai's sustainability hinges on building strong relationships with hospitals and doctors, but shaky ties may impact business model.Profit margin...
440 Views
Pre-IPO 160 Health (PHIP Updates) - Some Points Worth the Attention
The "high input, low output" model has led 160 Health into profit predicament when revenue fails to grow in tandem.Valuation would be lower than...
465 Views